More Than Meets the Eye: Scientific Rationale behind Molecular Imaging and Therapeutic Targeting of Prostate-Specific Membrane Antigen (PSMA) in Metastatic Prostate Cancer and Beyond

More Than Meets the Eye: Scientific Rationale behind Molecular Imaging and Therapeutic Targeting of Prostate-Specific Membrane Antigen (PSMA) in Metastatic Prostate Cancer and Beyond

Prostate cancer is the second most common cancer type in men globally. Although the prognosis for localized prostate cancer is good, no curative treatments are available for metastatic disease. Better diagnostic methods could help target therapies and improve the outcome. Prostate-specific membrane...

Full description

Bibliographic Details
Main Authors: Anniina Hyväkkä, Verneri Virtanen, Jukka Kemppainen, Tove J. Grönroos, Heikki Minn, Maria Sundvall
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Cancers
Subjects:
castration resistant prostate cancer (CRPC)
molecular imaging
positron emission tomography (PET)
prostate-specific membrane antigen (PSMA)
radionuclide therapy
therapeutic antibodies
Online Access:https://www.mdpi.com/2072-6694/13/9/2244

Internet

https://www.mdpi.com/2072-6694/13/9/2244

Similar Items